Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended September 2024 as against Rs 118.74 crore during the previous quarter ended September 2023. Sales declined 14.86% to Rs 506.88 crore in the quarter ended September 2024 as against Rs 595.36 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 506.88 | 595.36 | -15 |
| OPM % | 26.51 | 28.07 | - |
| PBDT | 142.55 | 172.06 | -17 |
| PBT | 127.46 | 158.93 | -20 |
| NP | 95.32 | 118.74 | -20 |